The HCV Drug Development Advisory Group (HCV Forum, formerly the HCV DrAG) Steering Committee members represent the HCV Forum's constituent groups and directs the Forum's work. The HCV Forum Steering Committee determines the issues that are appropriate for a review by the HCV Forum's and their scope. The Steering Committee members assist in project planning and in identifying experts from their constituencies to attend HCV Forum conferences and meetings.

 

Members of the committee are:  

Jean-Michel Pawlotsky, MD, PhD (co-chair)
Professor
Department of Bacteriology and Virology
Hopital Henri Mondor
Creteil, France 

Patrick Harrington, PhD
Microbiologist
U.S. Food and Drug Administration
Center for Drug Evaluation and Research/OND/OAP
Division of Antiviral Products
Silver Spring, MD

Daria Hazuda, PhD
Vice President, Worldwide Discovery Franchise Head for Infectious Diseases
Merck Research Laboratories
West Point, PA

Ira Jacobson, MD
Chief
Gastroenterology & Hepatology
Cornell University
New York, NY

Filip Josephson, MD, PhD

Clinical Assessor
Swedish Medical Products Agency/European Medicines Association
Uppsala, Sweden

Veronica Miller, PhD
Director
Forum for Collaborative HIV Research
Washington, DC

Andrew Muir, MD, MHS
Director
Gastroenterology & Hepatology
Duke University Medical Center
Durham, NC

Jeffrey Murray, MD, MPH
Deputy Director 
Division of Antiviral Products
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Stuart Ray, MD
Associate Professor of Medicine and Oncology
Division of Infectious Diseases
Center for Viral Hepatitis Research
Johns Hopkins University School of Medicine
Baltimore, MD

Kimberly A. Struble, PharmD
Medical Team Leader
Divison of Antiviral Products
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Heiner Wedemeyer, MD
Department of Gastroenterology, Hepatology and Endocrinology
Medizinische Hochschule Hannover 
Hannover, Germany